Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Journal of the American Academy of Dermatology
|
July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 29, 2022
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
Andreas Pinter, Luis Puig, Knut Schäkel, et al.
Annals of the Rheumatic Diseases
|
January 7, 2015
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Camille Roubille, Vincent Richer, Tara Starnino, et al.
Journal of the American Academy of Dermatology
|
September 20, 2020
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2021
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
Jonathan I Silverberg, Marjolein de Bruin-Weller, Thomas Bieber, et al.
Lancet (London, England)
|
April 19, 2025
Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial
Ana Maria Giménez-Arnau, Andreas Pinter, Wiebke Sondermann, et al.
The Journal of Rheumatology
|
May 3, 2016
Dr. Roubille, et al reply
Camille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research
|
November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials
Stephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery
|
November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)
Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
JAMA Dermatology
|
August 21, 2024
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial
April W Armstrong, Melinda Gooderham, Charles Lynde, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Journal of the American Academy of Dermatology
|
July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 29, 2022
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)
Andreas Pinter, Luis Puig, Knut Schäkel, et al.
Annals of the Rheumatic Diseases
|
January 7, 2015
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Camille Roubille, Vincent Richer, Tara Starnino, et al.
Journal of the American Academy of Dermatology
|
September 20, 2020
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2021
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
Jonathan I Silverberg, Marjolein de Bruin-Weller, Thomas Bieber, et al.
Lancet (London, England)
|
April 19, 2025
Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial
Ana Maria Giménez-Arnau, Andreas Pinter, Wiebke Sondermann, et al.
The Journal of Rheumatology
|
May 3, 2016
Dr. Roubille, et al reply
Camille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research
|
November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials
Stephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery
|
November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)
Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
JAMA Dermatology
|
August 21, 2024
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial
April W Armstrong, Melinda Gooderham, Charles Lynde, et al.
Page
of 15